Skip to main content
Caplight Logo









BionIT Labs

BionIT Labs

Private
SoletoHealthcare & Life Scienceshttps://bionitlabs.com/

Last Round

Series A

Jul 3, 2024

Est. Valuation

$1.97M

Total Funding Raised

$10.59M

Company Overview

BionIT Labs is a medical technology company that develops Adam's Hand, a fully-adaptive bionic hand prosthesis designed to improve the quality of life for people with upper-limb differences.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

bionic prosthesismyoelectric handbionic handupper-limb prostheticselectromyographyEMGadaptive gripsmart prosthesisprosthetic limbmed-techbiomedical engineeringassistive technologyprosthetic clinicorthopedic technologybionics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BionIT Labs Comparables

Compare BionIT Labs with similar companies based on industry and business-model similarity.

BionIT Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Esper Bionics
94%
Aether Biomedical
87%
COVVI
87%

BionIT Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 3, 2024
SeedNov 22, 2021
VC RoundDec 1, 2020
CrowdfundingSep 18, 2019
GrantAug 23, 2019
Accelerator
Mar 1, 2019

Key People

Founding team and executive leadership

Federico Gaetani

CTO Co-Founder

Founding Team

Matteo Aventaggiato

Chief Operating Officer, Co-founder CTO

Founding Team

Giovanni Antonio Zappatore

CEO Founder

Founding Team

BionIT Labs Investors

Notable investors and investment history

BionIT Labs investors
InvestorRounds
CDP Venture Capital SGRSeries A, VC Round, Seed
SEFEA ImpactSeries A
G-FactorAccelerator
SIMESTSeries A
ENEA-Tech and Biomedical FoundationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Demonstrated AI bionic prosthetic hand at CES 2026.

  • Sep 26, 2025

    Closed Canadian and Americas offices on September 26, 2025.

BionIT Labs Filings

Explore SEC and related filing metadata, where available.

BionIT Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BionIT Labs's valuation, stock price, and market status.

Is BionIT Labs a public or private company?

BionIT Labs is a private company.

What is the current stock price of BionIT Labs?

BionIT Labs is a private company with no public stock price. No recent secondary market data is available.

How much is BionIT Labs worth (valuation)?

Valuation information for BionIT Labs is not publicly available.

Can I buy BionIT Labs stock?

BionIT Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BionIT Labs's last funding round?

BionIT Labs's most recent funding round was Series A on July 3, 2024.

Who are the main investors in BionIT Labs?

Key investors in BionIT Labs include SEFEA Impact.

Will BionIT Labs IPO soon?

No public IPO plans have been announced for BionIT Labs.

How can I track BionIT Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BionIT Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSoleto
Employee Range55
Year Founded2018
Last FundingJul 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?